[ADPT] Adeptus Health Inc.


Type of security: Stock

Sector: Health Care

Industry: Hospital/Nursing Management

Market Capitalization:

Exchange: NYSE

The data is delayed by 15 minutes.


Price: 7.81 Change: 0 (0%)
Ext. hours: Change: 0 (0%)

chart ADPT

Refresh chart

Description: Adeptus Health Inc. focuses on operating a network of independent freestanding emergency rooms in the United States. It operates 32 facilities located in the Houston, Dallas/Fort Worth, San Antonio, and Austin of Texas, as well as Colorado Springs and Denver of Colorado. The company was founded in 2002 and is based in Lewisville, Texas.

Fundamental Ratios
Shares Outstanding EPS5.95 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 84.12% Sales Growth - Q/Q16.24% P/E0.24
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-0.91% ROE-5.61% ROI-1.31%
Current Ratio2.59 Quick Ratio2.46 Long Term Debt/Equity2.35 Debt Ratio0.72
Gross Margin Operating Margin-0.37% Net Profit Margin-1.09% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities23.26 M Cash From Investing Activities570 K Cash From Operating Activities-11.96 M Gross Profit31.88 M
Net Profit590 K Operating Profit5.35 M Total Assets302.29 M Total Current Assets91.56 M
Total Current Liabilities35.41 M Total Debt134.27 M Total Liabilities253.14 M Total Revenue80.76 M
Technical Data
High 52 week72.35 Low 52 week0.98 Last close1.41 Last change0%
RSI45.42 Average true range0.49 Beta1.12 Volume922.38 K
Simple moving average 20 days-10.39% Simple moving average 50 days-58.29% Simple moving average 200 days-93.46%
Performance Data
Performance Week-37.33% Performance Month-19.89% Performance Quart-82.4% Performance Half-96.28%
Performance Year-97.84% Performance Year-to-date-81.54% Volatility daily19.86% Volatility weekly44.4%
Volatility monthly90.99% Volatility yearly315.2% Relative Volume324.05% Average Volume2.39 M
New High New Low


2020-02-21 10:20:03 | MEDNAX MD Q4 Earnings and Revenues Surpass Estimates

2020-02-19 16:05:10 | Adaptive Biotechnologies to Present at the 40th Annual Cowen Health Care Conference

2020-02-12 16:05:10 | Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2019 Financial Results on February 26, 2020

2020-02-10 08:44:01 | Why Earnings Season Could Be Great for Adaptive ADPT

2020-02-03 11:27:34 | Andreas Halvorsen Trims Adaptive Biotechnologies Stake

2020-01-31 11:52:08 | Insiders Roundup: Texas Instruments, Homolody Medicines

2020-01-29 09:50:00 | Thermo Fisher Scientific Could Trade Higher in the Weeks and Months Ahead

2020-01-23 20:53:40 | Adaptive Announces Pricing of Public Offering of Common Stock

2020-01-22 08:25:41 | The Daily Biotech Pulse: Johnson & Johnson Earnings, FDA Nod For Horizon Therapeutics, Slew Of Secondary Offerings

2020-01-21 16:39:24 | Adaptive Announces Proposed Public Offering of Common Stock

2020-01-21 16:02:42 | Adaptive Announces Preliminary Unaudited Revenue for Full Year 2019

2020-01-13 07:30:10 | Adaptive and Genentech Partner to Use clonoSEQ® Assay to Measure Minimal Residual Disease as a Primary Endpoint in Phase III Study of Chronic Lymphocytic Leukemia Patients

2020-01-08 07:30:10 | Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Monitoring MRD in Patients With Chronic Lymphocytic Leukemia

2019-12-30 16:05:10 | Adaptive Biotechnologies to Present at the 38th Annual J.P. Morgan Healthcare Conference

2019-12-30 10:04:03 | Top Ranked Momentum Stocks to Buy for December 30th

2019-12-26 14:47:37 | Tech will drive change in health care throughout next decade

2019-12-20 16:17:13 | Is Adaptive Biotechnologies Corporation ADPT A Good Stock To Buy?

2019-12-16 21:24:39 | Chad Robins led Adaptive Biotechnologies through a huge 2019

2019-12-13 04:52:09 | Adaptive Biotechnologies Shares March Higher, Can It Continue?

2019-12-09 08:44:30 | Fiverr Languishes Below IPO Price as First Chance to Sell Nears

2019-12-09 08:00:10 | Adaptive and AbbVie Partner Across Multiple Myeloma Trials to Measure Minimal Residual Disease Using the clonoSEQ® Assay

2019-12-04 16:30:10 | Adaptive Biotechnologies and Collaborators to Present Data from More Than 25 clonoSEQ® Abstracts at ASH 2019 Demonstrating Clinical Relevance of Standardized, Accurate MRD Testing for Blood Cancer Patients

2019-12-03 16:34:49 | Hedge Funds Love Echostar Corporation SATS Way More Than These 4 Stocks

2019-11-22 03:01:00 | Seattle has potential as a biotech hub, but more companies must stay here and grow

2019-11-19 12:26:40 | Robertson's Tiger Management Buys Adobe, Facebook

2019-11-12 16:05:00 | Adaptive Biotechnologies Corporation Reports Third Quarter 2019 Financial Results

2019-11-11 09:28:02 | 4 Biotech Stocks That Could Keep Beating Wall Street

2019-10-29 16:05:05 | Adaptive Biotechnologies to Report Third Quarter Financial Results on November 12, 2019

2019-10-14 18:43:45 | Hedge Funds Have Never Been This Bullish On Adaptive Biotechnologies Corporation ADPT

2019-10-09 08:37:12 | Illumina ILMN Inks Deal to Commercialize NGS-Based IVD Kits

2019-09-26 07:13:13 | Do Insiders Own Shares In Adaptive Biotechnologies Corporation NASDAQ:ADPT?

2019-09-25 08:44:12 | Illumina ILMN Inks Deal to Develop Distributable Test Kits

2019-09-24 08:00:00 | Adaptive Biotechnologies Enters Partnership with Illumina to Develop Distributable IVD Test Kits for clonoSEQ and immunoSEQ Dx

2019-09-17 08:00:00 | Adaptive Biotechnologies Enters Partnership for Use Of clonoSEQ® as Preferred MRD Test for Drug Development Across Amgen’s Hematology Franchise

2019-09-08 19:45:55 | Here's Why Adaptive Biotechnologies Rose 31.9% in August

2019-08-16 16:22:07 | Andreas Halvorsen's Top 5 Buys of the 2nd Quarter

2019-08-14 09:05:00 | Adaptive Biotechnologies stock down 8.5% in premarket trade

2019-08-13 16:28:00 | Adaptive Biotech loss narrower than expected on first post IPO report

2019-08-13 16:05:00 | Adaptive Biotechnologies Corporation Reports Second Quarter 2019 Financial Results

2019-08-12 18:57:57 | Ron Baron Comments on Adaptive Biotechnologies Corp

2019-08-09 16:56:55 | New Listings Stink Up Earnings Season After Reports Disappoint

2019-08-07 17:20:10 | Adaptive Biotechnologies signs lease for new Seattle headquarters

2019-08-07 08:30:00 | Adaptive Biotechnologies Executes Lease for New 100,000 Square Foot Corporate Headquarters, Tripling its Footprint in Seattle’s Growing Biotech Hub

2019-08-01 16:15:00 | Adaptive Biotechnologies to Report Second Quarter Financial Results on August 13, 2019

2019-07-31 16:15:00 | Adaptive Biotechnologies Receives New York State CLEP Approval for clonoSEQ to Detect and Monitor Minimal Residual Disease MRD in Patients with Certain Blood Cancers

2019-07-24 07:10:00 | 3 Stocks the World's Best Investors Are Buying Right Now

2019-07-18 11:44:43 | Next-Generation Xbox Unveiled as China Production Cuts Loom

2019-07-12 15:55:03 | Sound Pharmaceuticals targets IPO in 2020

2019-07-01 16:32:00 | Why Freeport-McMoRan, Coty, and Adaptive Biotechnologies Slumped Today

2019-07-01 16:05:00 | Adaptive Biotechnologies Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares